AAPS PharmSciTech

, Volume 8, Issue 2, pp E94–E101 | Cite as

Chitosan film containing fucoidan as a wound dressing for dermal burn healing: Preparation and in vitro/in vivo evaluation

  • Ali Demir Sezer
  • Fatih Hatipoglu
  • Erdal Cevher
  • Zeki Oğurtan
  • Ahmet Levent Bas
  • Jülide Akbuğa


The aim of this study was to develop chitosan film containing fucoidan and to investigate its suitability for the treatment of dermal burns on rabbits. Porous films, thickness between 29.7 and 269.0 μm, were obtained by the solvent dropping method. Water vapor permeability (3.3–16.6/0.1 g), the swelling (0.67–1.77 g/g), tensile strength (7.1–45.8 N), and bioadhesion (0.076–1.771 mJ/cm2) of the films were determined. The thinnest films were obtained with the lowest chitosan concentration (P<.05). The water absorption capacity of the films sharply increased with the freeze-drying technique. The film having the thickness of 29.7 μm showed the highest amount of moisture permeability (16.6 g/0.1 g). Higher chitosan concentration significantly increased tensile strength of the films (P<.05). Using higher concentration of lactic acid made films more elastic and applicable, and these films were selected for in vivo studies. Seven adult male New Zealand white rabbits were used for the evaluation of the films on superficial dermal burns. Biopsy samples were taken at 7, 14, and 21 days after wounding, and each wound site was examined macroscopically and histopathologically. After 7 days treatment, fibroplasia and scar were observed on wounds treated with fucoidan-chitosan film. The best regenerated dermal papillary formation, best reepithelization, and the fastest closure of wounds were found in the fucoidan-chitosan film treatment group after 14 days compared with other treatment and control groups. It can be concluded that fucoidan-chitosan films might be a potential treatment system for dermal burns and that changing formulation variables can modulate the characterizations of the films.


Fucoidan chitosan biopolymer film wound healing 


  1. 1.
    Park JE, Barbul A. Understanding the role of immune regulation in wound healing.Am J Surg. 2004;187:S11-S16.CrossRefGoogle Scholar
  2. 2.
    Shakespeare P. Burn wound healing and skin substitutes.Burns. 2001;27:517–522.CrossRefGoogle Scholar
  3. 3.
    Lloyd LL, Kennedy JF, Methacanon P, Paterson M, Knill CJ. Carbohydrate polymers as wound management aids.Carbohydr Polym. 1998;37:315–322.CrossRefGoogle Scholar
  4. 4.
    Alemdaroğlu C, Değim Z, Çelebi N, Zor F, Öztürk S, Erdoğan D. An investigation on burn wound healing in rats with chitosan gel formulation containing epidermal growth factor.Burns. 2006;32:319–327.CrossRefGoogle Scholar
  5. 5.
    Ueno H, Murakami M, Okumura M, Kadosawa T, Uede T, Fujinaga T. Chitosan accelerates the production of osteopontin from polymorphonuclear leukocytes.Biomaterials. 2001;22:1667–1673.CrossRefGoogle Scholar
  6. 6.
    Pereira M, Mulloy B, Mourao PAS. Structure and anticoagulant activity of sulfated fucans.J Biol Chem. 1999;274:7656–7667.CrossRefGoogle Scholar
  7. 7.
    Fujimura T, Shibuya Y, Moriwaki S, et al.. Fucoidan is the active component of fucus vesiculosus that promotes contraction of fibroblast-populated collagen gels.Biol Pharm Bull. 2000;23:1180–1184.Google Scholar
  8. 8.
    O'Leary R, Rerek M, Wood EJ. Fucoidan modulates the effect of transforming growth factor (TGF)-β1 on fibroblast proliferation and wound repopulation in in vitro models of dermal wound repair.Biol Pharm Bull. 2004;27:266–270.CrossRefGoogle Scholar
  9. 9.
    Sezer AD, Cevher E, Akbuğa J. In vitro characterization of chitosan films containing fucoidan. Paper presented at: 12th International Pharmaceutical Technology Symposium; September 13–15, 2004; Istanbul, Turkey.Google Scholar
  10. 10.
    Remuñán-López C, Bodmeier R. Mechanical water uptake and permeability of crosslinked chitosan glutamate and alginate films.J Control Release. 1997;44:215–225.CrossRefGoogle Scholar
  11. 11.
    Shu XZ, Zhu KJ, Weihong S. Novel pH-sensitive citrate cross-linked chitosan film for drug controlled release.Int J Pharm. 2001;212:19–28.CrossRefGoogle Scholar
  12. 12.
    Kalapathy U, Proctor A, Shultz J. Production and properties of flexible sodium silicate films from rice hull ash silica.Bioresour Technol. 2000;72:99–106.CrossRefGoogle Scholar
  13. 13.
    Wong CF, Yuen KH, Peh KK. Formulation and evaluation of controlled release Eudragit buccal patches.Int J Pharm. 1999;178:11–22.CrossRefGoogle Scholar
  14. 14.
    Knabl JS, Bauer W, Andel H, et al. Progression of burn wound depth by systemical application of a vasoconstrictor: an experimental study with a new rabbit model.Burns. 1999;25:715–721.CrossRefGoogle Scholar
  15. 15.
    Derenzini M. The AgNORs.Micron. 2000;31:117–120.CrossRefGoogle Scholar
  16. 16.
    Trere D. AgNOR staining and quantification.Micron. 2000;31:127–131.CrossRefGoogle Scholar
  17. 17.
    Berthod F, Saintigny G, Chretien F, Hayek D, Collombel C, Damour O. Optimization of thickness, pore size and mechanical properties of a biomaterial designed for deep burn coverage.Clin Mater. 1994:15:259–265.CrossRefGoogle Scholar
  18. 18.
    Khan T, Peh K, Ch'ng H. Mechanical, bioadhesive strength and biological evaluations of chitosan films for wound dressing.J Pharm Pharm Sci. 2000;3:303–311.Google Scholar
  19. 19.
    Bangyekan C, Duangdao AO, Srikulkit K. Preparation and properties evaluation of chitosan-coated cassava starch films.Carbohydr Polym. 2006;63:61–71.CrossRefGoogle Scholar
  20. 20.
    Henriksen I, Green KL, Smart JD, Smistad G, Karlsen J. Bioadhesion of hydrated chitosans: an in vitro and in vivo study.Int J Pharm. 1996;145:231–240.CrossRefGoogle Scholar
  21. 21.
    Ishihara M, Nakanishia K, Ono K, et al. Photocrosslinkable chitosan as a dressing for wound occlusion and accelerator in healing process.Biomaterials. 2002;23:833–840.CrossRefGoogle Scholar
  22. 22.
    Smart JD. The basics and underlying mechanisms of mucoadhesion.Adv Drug Deliv Rev. 2005;57:1556–1568.CrossRefGoogle Scholar
  23. 23.
    Ueno H, Mori T, Fujinaga T. Topical formulation and wound healing applications of chitosan.Adv Drug Deliv Rev. 2001;52:105–115.CrossRefGoogle Scholar
  24. 24.
    Hideyuki S, Masato N, Toshiko K, Haruji S, Hidesuke H, Terou Y, inventors. Complex of fibroblast growth factor. Japan Patent (JP) application no.: JP/1996/10017498. January 20, 1998.Google Scholar
  25. 25.
    Provenzano PP, Alejandro-Osorio AL, Valhmu WB, Jensen KT, Vanderby R. Intrinsic fibroblast-mediated remodeling of damaged collagenous matrices in vivo.Matrix Biol. 2005;23:543–555.CrossRefGoogle Scholar
  26. 26.
    Eichler MJ, Carlson MA. Modeling dermal granulation tissue with the linear fibroblast-populated collagen matrix: a comparison with the round matrix model.J Dermatol Sci. 2006;41:97–108.CrossRefGoogle Scholar
  27. 27.
    Erdağ G, Sheridan RL. Fibroblasts improve performance of cultured composite skin substitutes on athymic mice.Burns. 2004;30:322–328.CrossRefGoogle Scholar

Copyright information

© American Association of Pharmaceutical Scientists 2007

Authors and Affiliations

  • Ali Demir Sezer
    • 1
  • Fatih Hatipoglu
    • 2
  • Erdal Cevher
    • 3
  • Zeki Oğurtan
    • 4
  • Ahmet Levent Bas
    • 5
  • Jülide Akbuğa
    • 1
  1. 1.Department of Pharmaceutical Biotechnology, Faculty of PharmacyMarmara UniversityHaydarpaşa, IstanbulTurkey
  2. 2.Department of Pathology, Faculty of VeterinarySelçuk UniversityKampüs, KonyaTurkey
  3. 3.Department of Pharmaceutical Technology, Faculty of PharmacyIstanbul UniversityBeyazit, IstanbulTurkey
  4. 4.Department of Surgery, Faculty of VeterinarySelçuk UniversityKampüs, KonyaTurkey
  5. 5.Department of Pharmacology, Faculty of VeterinarySelçuk UniversityKampüs, KonyaTurkey

Personalised recommendations